Vanguard Global Advisers
PASG icon

Vanguard Global Advisers’s Passage Bio PASG Stock Holding History

Vanguard Global Advisers’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.87K Hold
638
– – ﹤0.01% 3635
2026
Q2 		$3.11K Hold
638
– – ﹤0.01% 3587
2026
Q1 		$5.01K Buy
+638
New +$6.6K ﹤0.01% 3557

Other funds holding PASG

Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Deltec Asset Management
Deltec Asset Management New York $642M AUM 16.66% 1-Year Est. Return

Vanguard Global Advisers's PASG Position: Q3 2026 in Review

Vanguard Global Advisers held its Passage Bio (PASG) position steady in Q3 2026 at 638 shares worth $2.87K. The position accounts for ﹤0.01% of the portfolio, ranked #3635.

Vanguard Global Advisers first reported a position in PASG in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.01K in Q1 2026. 20 funds tracked by Wall St. Rank hold PASG as of Q3 2026.

  • Vanguard Global Advisers held 638 shares of Passage Bio worth $2.87K as of Q3 2026.
  • Vanguard Global Advisers left its Passage Bio share count unchanged in Q3 2026.
  • Passage Bio made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3635 holding.
  • Vanguard Global Advisers first reported a position in Passage Bio in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Passage Bio position peaked at $5.01K in Q1 2026.
  • 20 funds tracked by Wall St. Rank held Passage Bio as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.